Contact UsInvestorsCareersScienceContact Us
Investor Relations

FINANCIAL INFORMATION

Unaudited Results – Quarter ended December 31, 2025

Unaudited Results – Quarter ended September 30, 2025

Unaudited Results – Quarter Ended June 30, 2025 

2025-2026
2024-2025

Annual Report 2024-25

Audited Results - Year ended March 31, 2025

Integrated filing (Financial) for the quarter ended December 31, 2024

Unaudited Results – Quarter ended December 31, 2024

Unaudited Results – Quarter ended September 30, 2024

AGM held on August 28, 2024 – Proceedings

Unaudited Results – Quarter ended June 30, 2024

2023-2024

Annual Report 2023 – 24

Annual Return 2023-24

Audited Results – Year ended March 31, 2024

Unaudited Results – Quarter ended December 31, 2023

Unaudited Results – Quarter ended September 30, 2023

AGM held on August 18, 2023 – Proceedings

Unaudited Results – Quarter ended June 30, 2023

2022-2023

AGM held on August 18, 2023 – Proceedings

Annual Report 2022 – 23

Annual Return 2022 – 23

Audited Results – Year ended March 31, 2023

Quarter Ended December 31, 2022

Quarter Ended September 30, 2022

AGM held on August 26, 2022 – Proceedings

Quarter ended June 30, 2022

2021-2022

Annual Report 2021 – 22

Annual Return 2021 – 22

Audited Results- Year ended March 31, 2022

Quarter ended December 31, 2021

Quarter ended September 30, 2021

Quarter ended June 30, 2021

2020-2021

AGM held on August 19, 2021 – Proceedings

Annual Report 2020-21

Annual Report 2020-21 (Interactive Mode)

Annual Return 2020-21

Audited Results – Year ended March 31, 2021

Quarter ended December 31, 2020

Quarter ended September 30, 2020.

Quarter ended June 30, 2020

2019-2020

Annual Return 2019-20.​​​​​​​

AGM held on September 4, 2020 – Proceedings

Annual Report 2019 – 20

Audited Results – Year ended March 31, 2020.

Quarter ended December 31, 2019

Quarter ended September 30, 2019.

Quarter ended June 30, 2019

2018-2019

Annual Report 2018 – 19

Audited Results – Year ended March 31, 2019.

Quarter ended December 31, 2018

Quarter ended September 30, 2018

Quarter ended June 30, 2018

2017-2018

Annual Report 2017 – 18​​​​​​​

Audited Results – Year ended March 31, 2018.

Quarter ended December 31, 2017

Quarter ended September 30, 2017.

Quarter ended June 30, 2017.

2016-2017

Annual Report 2016 – 17​​​

Audited Results – Year ended March 31, 2017.

Quarter ended December 31, 2016

Quarter ended September 30, 2016.

Quarter ended June 30, 2016.

2015-2016

Annual Report 2015 - 2016

Audited Results - Year Ended March 31, 2016

Quarter ended December 31, 2015

Quarter ended September 30, 2015

Quarter ended June 30, 2015

2014-2015

Annual Report 2014 - 2015

Audited Results – Year Ended March 31, 2015

Quarter ended December 31, 2014

Quarter ended September 30, 2014

Quarter ended June 30, 2014

2013-2014

Annual Report 2013 - 2014

Audited Results – Year Ended March 31, 2014 

Quarter Ended December 31 2013 

Quarter Ended September 30 2013

Quarter Ended June 30 2013

2012-2013

Annual Report 2012 - 2013

Audited Results - Year Ended March 31 2013

Quarter Ended December 31 2012

Quarter Ended September 30 2012

Quarter Ended June 30 2012

2011-2012

Annual Report 2011 - 2012

Audited Results - Year Ended March 31 2012

Quarter Ended December 31 2011

Quarter Ended September 30 2011

Quarter Ended June 30 2011

About UsOur PeopleOur Community EffortsOur ProductsInvestors CareersMedia Adverse Event ReportingHealth Care ProfessionalsTerms of UsePrivacy PolicyContact UsCopyright © 2002- 2025 Pfizer Inc. All rights reserved.
Archives2010Annual Report 20112009Annual Report 2008 - 20092008Annual Report 2007 - 20082007Annual Report 2006 - 20072006Annual Report 2005 - 20062005Annual Report 2004 - 20052004Annual Report 2003 - 20042003Annual Report 2002 - 20032002Annual Report 2001 - 20022001Annual Report 2000 - 20012000Annual Report 1999 - 20001999Annual Report 1998 - 1999